Stocktoria
NextCure, Inc. NXTC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-09
NextCure, Inc. statistics & valuation
Market cap$5.9M
P / B0.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -111.3% | -68.8% | -49.0% | -40.6% | -28.6% |
| Return on equity | -159.8% | -85.0% | -54.8% | -44.6% | -29.7% |
| Debt / equity | — | — | — | 0.00× | 0.00× |
| Current ratio | 4.14 | 7.50 | 16.38 | 17.97 | 34.48 |
Source: SEC EDGAR filings · CIK 0001661059 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.